How to cite item

Anti-angiogenic agents in Non-Small-Cell Lung Cancer (NSCLC): a perspective on the MONET1 (Motesanib NSCLC Efficacy and Tolerability) study

   
@article{JTD559,
	author = {Millie Das and Heather Wakelee},
	title = {Anti-angiogenic agents in Non-Small-Cell Lung Cancer (NSCLC): a perspective on the MONET1 (Motesanib NSCLC Efficacy and Tolerability) study},
	journal = {Journal of Thoracic Disease},
	volume = {4},
	number = {6},
	year = {2012},
	keywords = {},
	abstract = {Since the discovery of the critical role played by angiogenesis in tumor growth and development (1), there has been increased interest in evaluating anti-angiogenic agents in the treatment of various malignancies, including non-small-cell lung cancer (NSCLC). Bevacizumab is a humanized monoclonal antibody to vascular endothelial growth factor (VEGF) and is approved for use in combination with chemotherapy in multiple countries for the treatment of patients with metastatic NSCLC.},
	issn = {2077-6624},	url = {https://jtd.amegroups.org/article/view/559}
}